Novo nordisk Said on Monday that it is ending its cooperation Snow and its Due to concerns about the sales of the telehaalth company and promoting the cheap knock-off of the weight loss drug wagovi.

HIMS & Hers shares fell nearly 20% in Paraket Trading on Monday.

In April, Novo Nordisk said it will happen Offer Vegovi To expand access to access to blockbuster injections such as Hims & Hers blockbuster injections through many telehealth companies No less supply now In America

The end of Vagovi deficiency meant that computing pharmacies were banned from making and selling legally cheaper, with the unexpected version of Vagovi – with rare exceptions. Telehealth companies have stated that patients may still require individual mixed versions of Wegovy due to the necessary reasons, such as allergies to some ingredients in the branded product.

But Novo Nordisk said on Monday that Himas and Hars have failed to follow the law which prevents the large -scale sales of mixed drugs under the “false barrier” of privatization. The drug manufacturer also accused the hospital of the hospital and its “misleading” marketing which is risking the patient’s safety.

A spokesperson for a Hims and hers did not immediately respond to the CNBC’s remarks request.